| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.05 | 0.8 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |